IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison Report
Performance
Performance Report
Suraksha Diagnostic IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 846.25 Cr. The company is based in Kolkata and caters to Healthcare - Hospitals And Clinic sector. ICICI Securities , Nuvama Wealth Management , SBI Capital Markets are the merchant bankers of Suraksha Diagnostic IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd July 2024.
Suraksha Diagnostic IPO posted revenues of ₹ 247.40 crores and PAT of ₹ 30.68 crores in FY25 on annualised basis.
Revenue:
₹ 242.80 Cr.
EBITDA Margin:
35.75
% 
Net Worth: ₹ 186.60 Cr.
Market Capitalisation:
₹ 2296.76 Cr.
P/E:
74.89 times
P/BV: 2.22 times
EV/EBITDA: 26.50 times
Financial results of Suraksha Diagnostic IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Jun-24 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 314.10 | 300.20 | 281.10 | 275.90 | |
| Net Worth | 186.60 | 179.10 | 155.40 | 145.80 | |
| Total Debt | 7.50 | 8.50 | 13.90 | 18.90 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
60.70
242.80 |
218.70 | 190.10 | 223.10 | |
EBITDA
EBITDA on annualised basis |
21.70
86.80 |
73.60 | 47.40 | 65.20 | |
PAT
PAT on annualised basis |
7.60
30.40 |
23.10 | 6.00 | 20.80 | |
Suraksha Diagnostic IPO PAT Margin is 12.52 % , ROCE (Return on Capital Employed) is 6.32 % as per latest financial. The below table shows Suraksha Diagnostic IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Jun-24 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| EBITDA Margin (%) | 35.75 | 33.65 | 24.93 | 29.22 |
| PAT Margin (%) | 12.52 | 10.56 | 3.16 | 9.32 |
| EPS (₹) | 1.49 | 4.43 | 1.22 | 3.91 |
| ROE (%) | 4.07 | 12.90 | 3.86 | 14.27 |
| ROCE (%) | 6.32 | 21.46 | 9.05 | 23.11 |
| ROA (%) | 2.42 | 7.69 | 2.13 | 7.54 |
| Debt to Equity | 0.04 | 0.05 | 0.09 | 0.13 |
The market Capitalisation of Suraksha Diagnostic IPO is ₹ 2296.76 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Suraksha Diagnostic IPO prospectus highlights an Return on Equity (ROE) of 4.07 % , Return on Assets (ROA) of 2.42 %, and an EBITDA Margin of 35.75 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Suraksha Diagnostic IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Suraksha Diagnostic IPO is ₹ 2296.76 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Suraksha Diagnostic IPO has a Price-to-Earnings (PE) ratio of 74.89 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Suraksha Diagnostic IPO reported revenue of ₹ 247.40 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Suraksha Diagnostic IPO provide insights into sales growth, market demand, and business scalability.
Suraksha Diagnostic recorded an EBITDA of ₹ 86.80 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Suraksha Diagnostic Profit After Tax (PAT) is ₹ 30.40 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 242.80 Cr.
EBITDA Margin:
35.75
%
Net Worth: ₹ 186.60 Cr.
Market Capitalisation:
₹ 2296.76 Cr.
P/E:
74.89 times
P/BV: 2.22 times
EV/EBITDA: 26.50 times
Suraksha Diagnostic operates in Healthcare - Hospitals And Clinic and Offers Pathology, Radiology Testing And Medical Consultancy Services. The Issue is listed on BSE,NSE in Dec, 2024. Suraksha Diagnostic IPO size was 846.25 with Issue price of 441.00 .
Merchant Banker(s) of Suraksha Diagnostic IPO: ICICI Securities Limited , Nuvama Wealth Management Limited , SBI Capital Markets Limited
Suraksha Diagnostic IPO subscription was 1.27 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Suraksha Diagnostic IPO listed at a listing price of 437.00 against the offer price of 441.00.
The current market price of Suraksha Diagnostic is 325.20.
Why Us?
